3/2
07:35 am
mplt
MapLight Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
MapLight Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/2
07:00 am
mplt
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
MapLight Therapeutics to Participate in Upcoming Investor Conferences
1/23
05:07 pm
mplt
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at
Weiss Ratings . They set a "sell (e)" rating on the stock.
Neutral
Report
Maplight Therapeutics (NASDAQ:MPLT) is now covered by analysts at
Weiss Ratings . They set a "sell (e)" rating on the stock.
1/9
07:41 am
mplt
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
Medium
Report
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 [Yahoo! Finance]
1/9
07:00 am
mplt
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Medium
Report
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
1/5
07:00 am
mplt
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
Low
Report
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
12/20
01:30 am
mplt
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
Medium
Report
Maplight Therapeutics (NASDAQ:MPLT) was upgraded by analysts at
Wall Str
12/16
07:00 am
mplt
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
Medium
Report
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
2/24
06:57 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 20 Filed by: Malenka Robert C.
Low
Report
Form 4 MapLight Therapeutics, For: Feb 20 Filed by: Malenka Robert C.
2/24
04:36 pm
mplt
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
Medium
Report
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
2/23
04:34 pm
mplt
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
Low
Report
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
2/20
06:25 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 18 Filed by: Pavlov George
Low
Report
Form 4 MapLight Therapeutics, For: Feb 18 Filed by: Pavlov George
2/20
04:16 pm
mplt
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
Low
Report
Form 144 MapLight Therapeutics, Filed by: Malenka Robert C.
2/18
07:33 pm
mplt
Form 4 MapLight Therapeutics, For: Feb 13 Filed by: Malenka Robert C.
Medium
Report
Form 4 MapLight Therapeutics, For: Feb 13 Filed by: Malenka Robert C.
2/17
10:29 am
mplt
Form SCHEDULE 13G MapLight Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
Low
Report
Form SCHEDULE 13G MapLight Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
2/17
08:32 am
mplt
Form SCHEDULE 13G MapLight Therapeutics, Filed by: Forbion Growth Opportunities Fund III Cooperatief U.A.
Low
Report
Form SCHEDULE 13G MapLight Therapeutics, Filed by: Forbion Growth Opportunities Fund III Cooperatief U.A.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register